Skip to content

Stock-Based Comp at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$52M+20.9%
Artivion logo
ArtivionAORT
$8.41M+4.6%
AngioDynamics logo
AngioDynamicsANGO
$2.68M+11.9%
AIR
AirSculpt Technologies, Inc.AIRS
$559K-54.9%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$13.07M+29.3%
AtriCure logo
AtriCureATRC
$11.27M+17.1%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's stock-based comp?
Apyx Medical Corporation (APYX) reported stock-based comp of $312K in Q1 2026.
How has Apyx Medical Corporation's stock-based comp changed year-over-year?
Apyx Medical Corporation's stock-based comp decreased by 30.8% year-over-year, from $451K to $312K.
What is the long-term trend for Apyx Medical Corporation's stock-based comp?
Over 4 years (2021 to 2025), Apyx Medical Corporation's stock-based comp has grown at a -20.8% compound annual growth rate (CAGR), from $5.09M to $2M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.